You are here: Home » Medical Subject Notes , Pathology Notes » Calcineurin inhibitors
Tolypocladium inflatum: Sandos (now Novartis) told employees to bring plastic bags and collect soil samples while on vacation so that they could test it for compounds that had antibiotic activity
soil collected from Hardanger Vidda, Norway, grew fungi. these fungi produced cyclosporine
it was tested for antibiotic activity and found to have none; it was almost thrown away when someone from the new drug development unit decided to screen it as a new drug because it had a novel structure
the immunosuppressive assay was positive
inject sheep RBC into mice
concurrently inject cyclosporine and look at mice antibody response. cyclosporine inhibited anti-sheep-RBC antibody production in mice
nothing bad happened if you injected the animals only cyclosporine and not sheep RBCs
however, the animals that they injected developed renal insufficiency
Cyclosporine
lipid-soluble, variable absorption; microemulsion is more predictable
Tacrolimus (FK506)
macrolide; well-absorbed
came from a bag of dirt from Mt. Tsukuba
Mechanism of action
cyclosporine/tacrolimus bind to cyclophilin/FKBP, impairing ability to activate calcineurin
NFAT (nuclear factor of activated T cells) doesn’t get dephosphorylated, so it does not go into the nucleus to upregulate transcription
this is easy to use with transplantation because you know when the patient’s immune response will be turned on. it will be turned on after you transplant the graft. it is harder to use in chronic inflammation because when you intervene, the immune response is already turned on
markedly diminishes IL-2 production
augments TGF-β
Uses
cyclosporine: 1980s
Tacrolimus: 1994
solid-organ transplants
not typically used together because of their similar mechanisms of action
Side effects
both drugs demonstrate dose-dependent nephrotoxicity, hypertension, dyslipidemia (also caused by prednisone), glucose intolerance (also caused by prednisone), hirsutism/hyperplasia of gums
with tacrolimus, hirsutism/gum hyperplasia is less common and diabetes is more common
Nephrotoxicity of calcineurin inhibitors
after 72 months, 25% of intestinal allograft recipients have chronic renal failure
in someone with a heart-lung transplant, you have to keep their immunosuppression very high because it can be their only hope. you can be more cavalier in kidney transplants because there is anyway always the option of dialysis
Drug interactions
they are metabolized by CYP3A system
drug inhibiting this enzyme augment blood concentrations of calcineurin inhibitor
Ca channel blockers
ketoconazole
erythromicin
HIV-protease inhibitors
glucocorticoids
grapefruit juice
drugs inducing CYP3A can decrease blood concentrations
nafcillin
rifampin
phenobarbital
Category: Medical Subject Notes , Pathology Notes
POST COMMENT
0 comments:
Post a Comment